Igor Rudychev PhD, MBA

Igor Rudychev is Vice President of Enterprise Analytics at Horizon Therapeutics. Igor has 20+ years of analytics experience and for the last 15 years, he has been specializing in Pharmaceutical Data Analytics, Patient-Level Data (APLD), Sales & Marketing Analytics, Resource Allocation & Optimization, Brand Analytics, and Forecasting. Prior to joining Pfizer, Igor was a Vice President of Operations with Bayser, a Management Consulting firm in Chicago, where he provided strategic and analytical insights to the top 20 global pharmaceutical companies. Igor has an MBA from the University of Chicago Booth School of Business and a Ph.D. in Theoretical Physics (Superstring Theory & Black Holes) from Texas A&M University.